Table 4.

Nocturnal Trial - Demographic and clinical characteristics for subjects with 12-month SBP declines of at least 30 mmHg. Changes (Δ) are calculated as F10–12 minus baseline (BL).

Pat #	Arm	Pre-HD SBP [mm Hg]		# Antihyper- tensive drugs		Age (yr)	Vintage (yr)	IDWG [kg]		Pre-HD Weight [kg]
		BL	Δ	BL	Δ			BL	Δ	BL	Δ
1	6× weekly	155	−43.1	2	−2	66.7	19.0	1.8	−0.55	89.5	−0.3
2	6× weekly	160	−41.9	2	−2	77.9	2.4	2.6	−1.27	90.6	−6.7
3	6× weekly	156	−40.7	1	0	48.4	0.9	2.8	−1.89	94.0	−0.6
4	3× weekly	194	−37.7	1	2	76.4	1.3	2.2	0.49	87.5	−1.3
5	3× weekly	177	−34.2	2	2	51.3	0.6	3.0	−1.06	56.2	1.1
6	6× weekly	154	−33.8	3	−3	58.4	0.6	3.0	−0.76	103.0	−12.4
7	3× weekly	166	−33.4	3	−3	45.1	3.6	2.0	0.13	97.3	−2.7
Remainder 3× weekly 1		151 [21.4]	0.9 [13.2]	1.6 [1.1]	0.0 [1.0]	53.8 [12.8]	3.4 [7.5]	2.4 [1.5]	0.2 [1.1]	86.1 [25.1]	0.9 [7.2]
Remainder 6× weekly 1		144 [13.5]	−4.1 [15.5]	1.9 [1.3]	−0.8 [1.7]	50.6 [14.2]	3.3 [4.9]	2.2 [1.4]	−0.1 [1.5]	89.5 [29.0]	0.9 [6.4]

¹Statistics for subjects with values at both baseline and F10–12.